If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one approach might be to design a compound
A. that increases phosphorylase activity.
B. to block G protein activity in liver cells.
C. that activates epinephrine receptors.
D.that increases cAMP production in liver cells.
E. that keeps sugar molecules from crossing the plasma membrane of liver cells.
Answer: B